NASDAQ: TECXTectonic Therapeutic Inc Stock Ownership - Who owns Tectonic Therapeutic?
Insider buying vs selling
Have Tectonic Therapeutic Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alise Reicin | CEO | 2026-10-26 | 10,000 | $2.38 | $23.80kBuy |
| Peter McNamara | CSci | 2026-09-30 | 536 | $23.04 | $12.35kSell |
| Marc Schwabish | CXO | 2026-09-25 | 411 | $23.67 | $9.73kSell |
| Daniel Lochner | CFO | 2026-09-25 | 520 | $23.67 | $12.31kSell |
| Peter McNamara | CSci | 2026-09-25 | 444 | $23.67 | $10.51kSell |
| Alise Reicin | CEO | 2026-09-25 | 1,545 | $23.67 | $36.57kSell |
| Marcella K. Ruddy | Med | 2026-09-25 | 525 | $23.67 | $12.43kSell |
| Peter McNamara | CSci | 2026-08-25 | 43 | $36.52 | $1.57kSell |
| Peter McNamara | CSci | 2026-08-25 | 43 | $14.71 | $632.53Buy |
| Peter McNamara | CSci | 2026-08-12 | 43 | $14.71 | $632.53Buy |
TECX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TECX insiders and whales buy or sell their stock.
TECX Shareholders
What type of owners hold Tectonic Therapeutic Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Timothy A. Springer | 30.82% | 6,024,338 | $119.16M | Insider |
| Bruce Booth | 28.48% | 5,567,289 | $110.12M | Insider |
| Braden Michael Leonard | 25.09% | 4,905,068 | $97.02M | Insider |
| Atlas Venture Fund X LP | 24.33% | 4,756,478 | $94.08M | Insider |
| Clarus Lifesciences III LP | 22.73% | 4,443,487 | $87.89M | Insider |
| Atlas Venture Associates X LP | 18.98% | 3,710,052 | $73.38M | Insider |
| Blackstone Holdings II LP | 15.15% | 2,962,325 | $58.59M | Insider |
| Scott Requadt | 15.15% | 2,962,325 | $58.59M | Insider |
| Atlas Venture Opportunity Fund I LP | 4.15% | 810,811 | $16.04M | Insider |
| Geoffrey MacKay | 3.98% | 778,343 | $15.40M | Insider |
TECX vs Biotech Stocks
Tectonic Therapeutic Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.